TotalMarketCap

Dermata Therapeutics

DRMANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.819 M

$0.77 -9.83%

Close of 6 Nov 2026

As of 6 Nov 2026, Dermata Therapeutics (DRMA) has a market capitalization of $3.82M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$7.56M

Loss-making

Shares outstanding

4,022,143

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #459Apimeds Pharmaceuticals USAPUS$4.05M
  2. #460NuCanaNCNA$3.89M
  3. #461Dermata TherapeuticsDRMA$3.82M
  4. #462RedHill BiopharmaRDHL$3.73M
  5. #463Cadrenal TherapeuticsCVKD$3.57M

What if Dermata Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$5,698,424

Per share 7,392,870× higher

Bitcoin $1.53T

$308,331.80

Per share 400,015× higher

Apple $5.02T

$1,012,225

Per share 1,313,213× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Dermata Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.